Compare Charles River Laboratories Intl. Inc (CRL) vs Crocs, Inc. (CROX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Crocs, Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $282.01 (market cap $13.46B), while Crocs, Inc. trades at $131.61 (market cap $6.31B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.1× Crocs, Inc.'s market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Crocs, Inc. nearer its low. Which is the better fit depends on your goals.
| CRL | CROX | |
|---|---|---|
Market Cap | $13.46B | $6.31B |
Sector | Health | Consumer Staples |
52-Week High | $282.00 | $141.19 |
52-Week Low | $145.57 | $73.39 |
Enterprise Value | $16.30B | $7.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →
